Purchases and Sales Made in Q1 2022 in Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX) during Q1 2022. The information is specifically focused on institutions that hold shares of Protagonist Therapeutics, Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2022
Q1 2022
|
Farallon Capital Management LLC
San Francisco, CA |
SELL
|
- |
-783K- 40.83% |
$18.3M - $28.2M
|
1.13M
$52M
|
|
|
May 16, 2022
Q1 2022
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-1.17MClosed |
$27.4M - $42.3M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Eco R1 Capital, LLC
San Francisco, CA |
SELL
|
- |
-2.26M- 85.54% |
$52.7M - $81.5M
|
382K
$17.5M
|